EUVIMEDEUVIMED entdecken
Crossref

AMLdb: a comprehensive multi-omics platform to identify biomarkers and drug targets for acute myeloid leukemia

Keerthana Vinod Kumar, Ambuj Kumar, Kavita Kundal, Avik Sengupta, Kunjulakshmi R, Subashani Singh, Bhanu Teja Korra, Simran Sharma, Vandana Suresh, Mayilaadumveettil Nishana, Rahul Kumar iD

Briefings in Functional Genomics · 2024

DOI: 10.1093/bfgp/elae024 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Briefings in Functional Genomics, 2024. Verfasst von Keerthana Vinod Kumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Indian Institute of Technology Hyderabad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Acute myeloid leukemia (AML) is one of the leading leukemic malignancies in adults. The heterogeneity of the disease makes the diagnosis and treatment extremely difficult. With the advent of next-generation sequencing (NGS) technologies, exploration at the molecular level for the identification of biomarkers and drug targets has been the focus for the researchers to come up with novel therapies for better prognosis and survival outcomes of AML patients. However, the huge amount of data from NGS platforms requires a comprehensive AML platform to streamline literature mining efforts and save time. To facilitate this, we developed AMLdb, an interactive multi-omics platform that allows users to query, visualize, retrieve, and analyse AML related multi-omics data. AMLdb contains 86 datasets for gene expression profiles, 15 datasets for methylation profiles, CRISPR-Cas9 knockout screens of 26 AML cell lines, sensitivity of 26 AML cell lines to 288 drugs, mutations in 41 unique genes in 23 AML cell lines, and information on 41 experimentally validated biomarkers. In this study, we have reported five genes, i.e. CBFB, ENO1, IMPDH2, SEPHS2, and MYH9 identified via our analysis using AMLdb. ENO1 is uniquely identified gene which requires further investigation as a novel potential target while other reported genes have been previously confirmed as targets through experimental studies. Top of form we believe that these findings utilizing AMLdb can make it an invaluable resource to accelerate the development of effective therapies for AML and assisting the research community in advancing their understanding of AML pathogenesis. AMLdb is freely available at https://project.iith.ac.in/cgntlab/amldb.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leukemia, Myeloid, AcuteBiomarkers, TumorHumansMolecular Targeted TherapyGenomicsDatabases, GeneticMultiomics

Stichwörter der Autor:innen

acute myeloid leukemiabiomarkersdatabasedrug targetsmutationnext generation sequencing (NGS)

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana 502284, India.
  • Department of Biological Sciences, Indian Institute of Science Education and Research, Berhampur, Odisha 760010, India.
  • School of Biology, Indian Institute of Science Education and Research, Thiruvananthapuram, Maruthamala P. O., Vithura, Kerala 695551, India.

ORCID-Profile: Rahul Kumar

Förderung

  • Indian Institute of Technology Hyderabad

Zitieren

APA

Vinod Kumar, K., Kumar, A., Kundal, K., Sengupta, A., R, K., Singh, S., Korra, B. T., Sharma, S., Suresh, V., Nishana, M., & Kumar, R. (2024). AMLdb: a comprehensive multi-omics platform to identify biomarkers and drug targets for acute myeloid leukemia. Briefings in Functional Genomics. https://doi.org/10.1093/bfgp/elae024

Vancouver

Vinod Kumar K, Kumar A, Kundal K, Sengupta A, R K, Singh S, et al. AMLdb: a comprehensive multi-omics platform to identify biomarkers and drug targets for acute myeloid leukemia. Briefings in Functional Genomics. 2024. doi:10.1093/bfgp/elae024

BibTeX
@article{VinodKumar2024,
  author = {Vinod Kumar, Keerthana and Kumar, Ambuj and Kundal, Kavita and Sengupta, Avik and R, Kunjulakshmi and Singh, Subashani and Korra, Bhanu Teja and Sharma, Simran and Suresh, Vandana and Nishana, Mayilaadumveettil and Kumar, Rahul},
  title = {AMLdb: a comprehensive multi-omics platform to identify biomarkers and drug targets for acute myeloid leukemia},
  journal = {Briefings in Functional Genomics},
  year = {2024},
  doi = {10.1093/bfgp/elae024}
}
Kostenlos starten →